CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($) |
Pre-funded warrants
Common Stock
|
Pre-funded warrants
Additional Paid-In Capital
|
Pre-funded warrants |
Preferred Stock
Series E-2 Preferred Stock
|
Preferred Stock
Series E-3 preferred stock
|
Preferred Stock
Series E-4 preferred stock
|
Preferred Stock |
Common Stock
Series E-2 Preferred Stock
|
Common Stock
Series E-3 preferred stock
|
Common Stock
Series E-4 preferred stock
|
Common Stock |
Additional Paid-In Capital
Series E-2 Preferred Stock
|
Additional Paid-In Capital
Series E-3 preferred stock
|
Additional Paid-In Capital
Series E-4 preferred stock
|
Additional Paid-In Capital |
Accumulated Deficit |
Series D preferred stock |
Series E-2 Preferred Stock |
Series E-4 preferred stock |
Total |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Balance beginning at Dec. 31, 2022 | $ 94 | $ 168,143,557 | $ (159,990,407) | $ 8,153,244 | ||||||||||||||||
Balance beginning (in shares) at Dec. 31, 2022 | 9,385,272 | |||||||||||||||||||
Balance beginning Series D preferred stock at Dec. 31, 2022 | $ 1,382,023 | |||||||||||||||||||
Balance beginning Series D preferred stock (in shares) at Dec. 31, 2022 | 111.11 | |||||||||||||||||||
Stock-based compensation | 2,410,288 | 2,410,288 | ||||||||||||||||||
Exercise of warrants into common shares | $ 12 | 2,467,210 | $ 2,467,222 | |||||||||||||||||
Exercise of warrants into common shares (in shares) | 1,197,622 | |||||||||||||||||||
Conversion of preferred stock to common stock | $ (13,142,368) | $ 99 | 13,142,269 | |||||||||||||||||
Conversion of preferred stock to common stock (in shares) | (905.24) | 9,947,684 | ||||||||||||||||||
Reclassification of pre-funded warrants to liability liability | $ (3,239,112) | $ (3,239,112) | ||||||||||||||||||
Stock awards | $ 2 | (2) | ||||||||||||||||||
Stock awards (in shares) | 213,532 | 1,617,000 | ||||||||||||||||||
Fair value of the warrants allocated to preferred stock | $ 17,820,000 | $ 17,820,000 | ||||||||||||||||||
Issuance of preferred stock, net of issuance costs (in shares) | 1,225 | |||||||||||||||||||
Net loss | (42,770,610) | $ (42,770,610) | ||||||||||||||||||
Balance ending Series D preferred stock at Dec. 31, 2023 | $ 1,382,023 | |||||||||||||||||||
Balance ending Series D preferred stock (in shares) at Dec. 31, 2023 | 111.11 | |||||||||||||||||||
Balance ending at Dec. 31, 2023 | $ 4,677,632 | $ 207 | 182,924,210 | (202,761,017) | (15,158,968) | |||||||||||||||
Balance ending (in shares) at Dec. 31, 2023 | 319.76 | 20,744,110 | ||||||||||||||||||
Stock-based compensation | 4,272,780 | 4,272,780 | ||||||||||||||||||
Exercise of warrants into common shares | $ 11 | $ 3,972,529 | $ 3,972,540 | $ 5 | 2,298,138 | 2,298,143 | ||||||||||||||
Exercise of warrants into common shares (in shares) | 1,079,132 | 547,177 | ||||||||||||||||||
Exercise of warrants for preferred stock, net of issuance costs | $ 47,577,000 | $ 47,577,000 | ||||||||||||||||||
Exercise of warrants for preferred stock, net of issuance costs (in shares) | 2,205 | |||||||||||||||||||
Conversion of preferred stock to common stock | $ (4,156,854) | $ (47,577,000) | $ (15,914,632) | $ 31 | $ 139 | $ 68 | $ 4,156,823 | $ 47,576,861 | $ 15,914,564 | |||||||||||
Conversion of preferred stock to common stock (in shares) | (284) | (2,205) | (1,610) | 3,122,637 | 13,846,141 | 6,739,919 | ||||||||||||||
Stock awards (in shares) | 3,063,500 | |||||||||||||||||||
Fair value of the warrants allocated to preferred stock | $ (15,914,632) | $ (15,914,632) | ||||||||||||||||||
Issuance of preferred stock, net of issuance costs (in shares) | 1,610 | |||||||||||||||||||
Stock option exercise into common stock (in shares) | 767 | 1,667 | ||||||||||||||||||
Retired shares (in shares) | (8) | |||||||||||||||||||
Net loss | (44,581,446) | $ (44,581,446) | ||||||||||||||||||
Balance ending Series D preferred stock at Dec. 31, 2024 | $ 1,382,023 | |||||||||||||||||||
Balance ending Series D preferred stock (in shares) at Dec. 31, 2024 | 111.11 | |||||||||||||||||||
Balance ending at Dec. 31, 2024 | $ 520,778 | $ 461 | $ 261,115,905 | $ (247,342,463) | $ 14,294,681 | |||||||||||||||
Balance ending (in shares) at Dec. 31, 2024 | 35.6 | 46,079,875 |
X | ||||||||||
- Definition Amount of decrease in the additional paid in capital (APIC) resulting from the reclassifications of warrants to liability. No definition available.
|
X | ||||||||||
- Definition Number of shares issued at exercise of warrants into common shares. No definition available.
|
X | ||||||||||
- Definition Amount of exercise of warrants into common shares values. No definition available.
|
X | ||||||||||
- Definition Number of shares issued at exercise of warrants into preferred shares. No definition available.
|
X | ||||||||||
- Definition Amount of exercise of warrants into preferred shares. No definition available.
|
X | ||||||||||
- Definition Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Value, before forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). No definition available.
|
X | ||||||||||
- Definition Number of shares issued during the period as a result of the conversion of convertible securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of share options (or share units) exercised during the current period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The gross value of stock issued during the period upon the conversion of convertible securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of shares of common and preferred stock retired from treasury during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|